PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER

PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER was reported 542 times

These side effects are most commonly reported by patients taking PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER:

# Side effect Count
0 NO ADVERSE EVENT 237
1 DEVICE ISSUE 211
2 PRODUCT PREPARATION ISSUE 184
3 DEVICE LEAKAGE 21
4 INFUSION SITE EXTRAVASATION 21
5 DEEP VEIN THROMBOSIS 20
6 DRUG INEFFECTIVE 19
7 CEREBRAL INFARCTION 14
8 HAEMORRHAGE 14
9 PULMONARY EMBOLISM 14
10 HYPOTENSION 13
11 INTERNATIONAL NORMALISED RATIO INCREASED 13
12 OFF LABEL USE 13
13 CEREBROVASCULAR ACCIDENT 12
14 EXTRAVASATION 11
15 THROMBOSIS 11
16 CARDIAC ARREST 9
17 CEREBRAL HAEMORRHAGE 9
18 ACUTE MYOCARDIAL INFARCTION 8
19 EMBOLISM 7
20 HAEMORRHAGE INTRACRANIAL 7
21 PRODUCT CLOSURE ISSUE 7
22 PRODUCT LABEL CONFUSION 7
23 GASTROINTESTINAL HAEMORRHAGE 6
24 INJECTION SITE EXTRAVASATION 6
25 SUBDURAL HAEMATOMA 6
26 ACCIDENTAL EXPOSURE TO PRODUCT 5
27 ACUTE KIDNEY INJURY 5
28 ANAEMIA 5
29 COAGULOPATHY 5
30 DEVICE DEFECTIVE 5
31 DEVICE MALFUNCTION 5
32 FALL 5
33 INCORRECT DOSE ADMINISTERED 5
34 INFUSION SITE SWELLING 5
35 ISCHAEMIC STROKE 5
36 PERIPHERAL SWELLING 5
37 APHASIA 4
38 CONFUSIONAL STATE 4
39 DEVICE CONNECTION ISSUE 4
40 DEVICE PHYSICAL PROPERTY ISSUE 4
41 DISSEMINATED INTRAVASCULAR COAGULATION 4
42 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
43 DYSPNOEA 4
44 EMBOLIC STROKE 4
45 HAEMATURIA 4
46 HEADACHE 4
47 MYOCARDIAL INFARCTION 4
48 SEPSIS 4
49 SEPTIC SHOCK 4
50 SHOCK HAEMORRHAGIC 4
51 UNRESPONSIVE TO STIMULI 4
52 ABDOMINAL PAIN 3
53 ADMINISTRATION SITE EXTRAVASATION 3
54 ANAPHYLACTIC REACTION 3
55 CEREBRAL HAEMATOMA 3
56 DEATH 3
57 DEVICE BREAKAGE 3
58 DRUG INTERACTION 3
59 HAEMOGLOBIN DECREASED 3
60 HYPERSENSITIVITY 3
61 HYPOAESTHESIA 3
62 INCORRECT DRUG ADMINISTRATION RATE 3
63 INTESTINAL ISCHAEMIA 3
64 MENTAL STATUS CHANGES 3
65 OVERDOSE 3
66 PAIN 3
67 PAIN IN EXTREMITY 3
68 PRODUCT DISPENSING ERROR 3
69 PRODUCT PREPARATION ERROR 3
70 PRODUCT QUALITY ISSUE 3
71 RASH 3
72 SUBARACHNOID HAEMORRHAGE 3
73 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 3
74 THROMBOCYTOPENIA 3
75 ALTERED STATE OF CONSCIOUSNESS 2
76 ANGIOEDEMA 2
77 ANXIETY 2
78 ATRIAL FIBRILLATION 2
79 BLOOD PRESSURE DECREASED 2
80 BRAIN HERNIATION 2
81 BURNING SENSATION 2
82 CARDIAC FAILURE 2
83 CEREBELLAR INFARCTION 2
84 CEREBRAL ISCHAEMIA 2
85 CHEST PAIN 2
86 CHILLS 2
87 COMPARTMENT SYNDROME 2
88 DEVICE FAILURE 2
89 DIVERTICULITIS 2
90 DIZZINESS 2
91 DRUG ADMINISTRATION ERROR 2
92 DRUG PRESCRIBING ERROR 2
93 ECCHYMOSIS 2
94 EMERGENCY CARE 2
95 EXPIRED PRODUCT ADMINISTERED 2
96 EXTRA DOSE ADMINISTERED 2
97 FLUSHING 2
98 GASTROINTESTINAL NECROSIS 2
99 HAEMATOCHEZIA 2
100 HAEMATOCRIT DECREASED 2
101 HAEMATOMA 2
102 HAEMODYNAMIC INSTABILITY 2
103 HEMIPLEGIA 2
104 HEPATIC FAILURE 2
105 HEPATIC ISCHAEMIA 2
106 HOSPITALISATION 2
107 HYDRONEPHROSIS 2
108 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
109 INFUSION SITE PAIN 2
110 INJECTION SITE SWELLING 2
111 INJURY ASSOCIATED WITH DEVICE 2
112 INTERNAL HAEMORRHAGE 2
113 INTERNATIONAL NORMALISED RATIO ABNORMAL 2
114 ISCHAEMIA 2
115 LIMB INJURY 2
116 LIQUID PRODUCT PHYSICAL ISSUE 2
117 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2
118 MEAN CELL HAEMOGLOBIN DECREASED 2
119 MEDICATION ERROR 2
120 MONOCYTE PERCENTAGE INCREASED 2
121 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2
122 NEUTROPENIA 2
123 NORMOCHROMIC NORMOCYTIC ANAEMIA 2
124 OEDEMA 2
125 OXYGEN SATURATION DECREASED 2
126 PERITONITIS 2
127 PLATELET COUNT DECREASED 2
128 PNEUMONIA 2
129 PNEUMONIA ASPIRATION 2
130 PRODUCT CONTAINER ISSUE 2
131 PRODUCT LABEL ISSUE 2
132 PRODUCT LEAKAGE 2
133 PRODUCT PACKAGING CONFUSION 2
134 PRODUCT RECONSTITUTION ISSUE 2
135 PRODUCT SOLUBILITY ABNORMAL 2
136 PRODUCT USE COMPLAINT 2
137 PRODUCT USE IN UNAPPROVED INDICATION 2
138 PULSELESS ELECTRICAL ACTIVITY 2
139 PYELONEPHRITIS 2
140 PYREXIA 2
141 RED CELL DISTRIBUTION WIDTH INCREASED 2
142 SWELLING 2
143 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
144 THROMBOPHLEBITIS SUPERFICIAL 2
145 TISSUE INFILTRATION 2
146 UNDERDOSE 2
147 UPPER GASTROINTESTINAL HAEMORRHAGE 2
148 URINARY TRACT INFECTION 2
149 WEIGHT INCREASED 2
150 WHITE BLOOD CELL COUNT DECREASED 2
151 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
152 ABSCESS NECK 1
153 ACCIDENTAL OVERDOSE 1
154 ACQUIRED HAEMOPHILIA 1
155 ACUTE CORONARY SYNDROME 1
156 ADMINISTRATION SITE BRUISE 1
157 ADMINISTRATION SITE SWELLING 1
158 ANAEMIA OF CHRONIC DISEASE 1
159 ANTI FACTOR VIII ANTIBODY INCREASED 1
160 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1
161 AORTIC DISORDER 1
162 ASPARTATE AMINOTRANSFERASE INCREASED 1
163 ASTHENIA 1
164 ATELECTASIS 1
165 ATRIAL THROMBOSIS 1
166 BLOOD CREATININE INCREASED 1
167 BLOOD CULTURE POSITIVE 1
168 BLOOD FIBRINOGEN DECREASED 1
169 BLOOD GLUCOSE INCREASED 1
170 BLOOD LACTIC ACID INCREASED 1
171 BLOOD LOSS ANAEMIA 1
172 BLOOD POTASSIUM DECREASED 1
173 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1
174 BLOOD URINE PRESENT 1
175 BRADYCARDIA 1
176 BRAIN CANCER METASTATIC 1
177 BRAIN COMPRESSION 1
178 BRAIN DEATH 1
179 BRAIN INJURY 1
180 BRAIN OEDEMA 1
181 BRAIN STEM HAEMORRHAGE 1
182 BRONCHOSPASM 1
183 CANDIDA INFECTION 1
184 CARBON DIOXIDE DECREASED 1
185 CARDIAC VALVE DISEASE 1
186 CARDIAC VENTRICULAR THROMBOSIS 1
187 CARDIO-RESPIRATORY ARREST 1
188 CARDIOGENIC SHOCK 1
189 CARPAL TUNNEL SYNDROME 1
190 CATHETER SITE THROMBOSIS 1
191 CELLULITIS 1
192 CENTRAL NERVOUS SYSTEM LESION 1
193 CEREBELLAR HAEMORRHAGE 1
194 CEREBRAL AMYLOID ANGIOPATHY 1
195 CEREBRAL ARTERY OCCLUSION 1
196 CEREBRAL DISORDER 1
197 CHOLANGITIS 1
198 CHOLECYSTITIS ACUTE 1
199 CHRONIC KIDNEY DISEASE 1
200 CIRCULATORY COLLAPSE 1
201 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
202 CLOSTRIDIUM DIFFICILE INFECTION 1
203 COAGULATION TEST ABNORMAL 1
204 COGNITIVE DISORDER 1
205 COLITIS ISCHAEMIC 1
206 COMA 1
207 COMPLICATION ASSOCIATED WITH DEVICE 1
208 CONDITION AGGRAVATED 1
209 COSTOVERTEBRAL ANGLE TENDERNESS 1
210 CRANIOTOMY 1
211 CRITICAL ILLNESS 1
212 CYTOKINE RELEASE SYNDROME 1
213 DEVICE DIFFICULT TO USE 1
214 DEVICE OPERATIONAL ISSUE 1
215 DISORIENTATION 1
216 DOSE CALCULATION ERROR 1
217 DRUG ABUSE 1
218 DRUG DISPENSING ERROR 1
219 DYSARTHRIA 1
220 EMBOLIC CEREBRAL INFARCTION 1
221 EMOTIONAL DISTRESS 1
222 ENDOCARDITIS 1
223 ENDOTRACHEAL INTUBATION 1
224 EPIDURAL HAEMORRHAGE 1
225 ERYTHEMA 1
226 EXPOSURE TO UNSPECIFIED AGENT 1
227 EXPOSURE VIA SKIN CONTACT 1
228 EYE IRRITATION 1
229 EYE PAIN 1
230 FACTOR VIII DEFICIENCY 1
231 FACTOR XA ACTIVITY INCREASED 1
232 FASCIOTOMY 1
233 FATIGUE 1
234 FEELING HOT 1
235 FIBRIN D DIMER INCREASED 1
236 FINE MOTOR SKILL DYSFUNCTION 1
237 FLUID OVERLOAD 1
238 FUNGAL INFECTION 1
239 GAIT DISTURBANCE 1
240 GASTROINTESTINAL DISORDER 1
241 GENERAL PHYSICAL CONDITION DECREASED 1
242 GENERAL PHYSICAL HEALTH DETERIORATION 1
243 GENERALISED TONIC-CLONIC SEIZURE 1
244 GENITAL HAEMORRHAGE 1
245 GLOMERULAR FILTRATION RATE DECREASED 1
246 HAEMATEMESIS 1
247 HAEMOGLOBIN 1
248 HAEMOPTYSIS 1
249 HAEMORRHAGE URINARY TRACT 1
250 HAEMORRHAGIC INFARCTION 1
251 HAEMORRHAGIC OVARIAN CYST 1
252 HAEMORRHAGIC STROKE 1
253 HAEMORRHAGIC TRANSFORMATION STROKE 1
254 HALLUCINATION, VISUAL 1
255 HEMIPARESIS 1
256 HEPARIN-INDUCED THROMBOCYTOPENIA 1
257 HEPATIC ENZYME INCREASED 1
258 HEPATITIS B ANTIBODY POSITIVE 1
259 HEPATITIS C 1
260 HEPATITIS C ANTIBODY POSITIVE 1
261 HYPERTROPHIC SCAR 1
262 HYPOVOLAEMIC SHOCK 1
263 HYPOXIA 1
264 IMMATURE GRANULOCYTE COUNT INCREASED 1
265 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1
266 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
267 INCORRECT PRODUCT ADMINISTRATION DURATION 1
268 INFUSION SITE BRUISING 1
269 INFUSION SITE DISCOLOURATION 1
270 INFUSION SITE DISCOMFORT 1
271 INFUSION SITE ERYTHEMA 1
272 INFUSION SITE INFLAMMATION 1
273 INFUSION SITE MASS 1
274 INFUSION SITE NECROSIS 1
275 INFUSION SITE OEDEMA 1
276 INFUSION SITE RASH 1
277 INFUSION SITE THROMBOSIS 1
278 INFUSION SITE VESICLES 1
279 INFUSION SITE WARMTH 1
280 INHIBITORY DRUG INTERACTION 1
281 INJECTION SITE ERYTHEMA 1
282 INJECTION SITE MASS 1
283 INTERCEPTED MEDICATION ERROR 1
284 INTERCEPTED PRODUCT PRESCRIBING ERROR 1
285 INTERCEPTED PRODUCT SELECTION ERROR 1
286 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1
287 INTERSTITIAL LUNG DISEASE 1
288 INTESTINAL INFARCTION 1
289 INTESTINAL MASS 1
290 INTESTINAL OBSTRUCTION 1
291 INTRACARDIAC PRESSURE INCREASED 1
292 INTRACARDIAC THROMBUS 1
293 INTRACRANIAL VENOUS SINUS THROMBOSIS 1
294 INTRAVENTRICULAR HAEMORRHAGE 1
295 ISCHAEMIC HEPATITIS 1
296 JUGULAR VEIN THROMBOSIS 1
297 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1
298 LIVER FUNCTION TEST INCREASED 1
299 LIVER INJURY 1
300 LOWER GASTROINTESTINAL HAEMORRHAGE 1
301 LYMPHOCYTE COUNT DECREASED 1
302 LYMPHOCYTE PERCENTAGE DECREASED 1
303 MEDICAL DEVICE SITE HAEMORRHAGE 1
304 MEDICAL DEVICE SITE THROMBOSIS 1
305 MELAENA 1
306 MENINGITIS 1
307 METABOLIC ENCEPHALOPATHY 1
308 METAPNEUMOVIRUS INFECTION 1
309 MUSCULOSKELETAL STIFFNESS 1
310 MYDRIASIS 1
311 NECROTISING FASCIITIS 1
312 NECROTISING SOFT TISSUE INFECTION 1
313 NEEDLE ISSUE 1
314 NERVOUS SYSTEM DISORDER 1
315 NEUTROPHIL COUNT DECREASED 1
316 NEUTROPHIL PERCENTAGE DECREASED 1
317 NIGHT SWEATS 1
318 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1
319 OCCUPATIONAL EXPOSURE TO PRODUCT 1
320 OEDEMA PERIPHERAL 1
321 PACKAGING DESIGN ISSUE 1
322 PALPITATIONS 1
323 PANCREATIC DISORDER 1
324 PARAESTHESIA 1
325 PELVIC HAEMATOMA 1
326 PERIPHERAL ISCHAEMIA 1
327 PERONEAL NERVE PALSY 1
328 PETECHIAE 1
329 PHARYNGEAL OEDEMA 1
330 PHYSICAL PRODUCT LABEL ISSUE 1
331 PLATELET COUNT ABNORMAL 1
332 PLEURAL EFFUSION 1
333 PNEUMONIA NECROTISING 1
334 POOR QUALITY PRODUCT ADMINISTERED 1
335 POOR VENOUS ACCESS 1
336 PORTAL VEIN THROMBOSIS 1
337 POST PROCEDURAL COMPLICATION 1
338 PROCEDURAL HAEMORRHAGE 1
339 PROCEDURAL SITE REACTION 1
340 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
341 PRODUCT ADMINISTRATION ERROR 1
342 PRODUCT APPEARANCE CONFUSION 1
343 PRODUCT COMMUNICATION ISSUE 1
344 PRODUCT COMPOUNDING QUALITY ISSUE 1
345 PRODUCT DOSE OMISSION ISSUE 1
346 PRODUCT OUTER PACKAGING ISSUE 1
347 PRODUCT PRESCRIBING ERROR 1
348 PRODUCT PRESCRIBING ISSUE 1
349 PRODUCT RECONSTITUTION QUALITY ISSUE 1
350 PRODUCT SELECTION ERROR 1
351 PRODUCT STORAGE ERROR 1
352 PRODUCT USE ISSUE 1
353 PROTHROMBIN LEVEL INCREASED 1
354 PROTHROMBIN TIME PROLONGED 1
355 PULMONARY ARTERY THROMBOSIS 1
356 PULMONARY HYPERTENSION 1
357 PULMONARY MASS 1
358 PULMONARY OEDEMA 1
359 PULSE ABSENT 1
360 PUPIL FIXED 1
361 PUPILS UNEQUAL 1
362 RECTAL HAEMORRHAGE 1
363 RED BLOOD CELL COUNT DECREASED 1
364 RED BLOOD CELL TRANSFUSION 1
365 RENAL ARTERY OCCLUSION 1
366 RENAL ARTERY THROMBOSIS 1
367 RENAL FAILURE 1
368 RESPIRATORY ARREST 1
369 RESPIRATORY DISORDER 1
370 RESPIRATORY FAILURE 1
371 RETROPERITONEAL HAEMORRHAGE 1
372 ROAD TRAFFIC ACCIDENT 1
373 SCRATCH 1
374 SENSORY LOSS 1
375 SERRATIA SEPSIS 1
376 SHOCK 1
377 SILENT MYOCARDIAL INFARCTION 1
378 SKIN DISCOLOURATION 1
379 SKIN EXFOLIATION 1
380 SKIN LACERATION 1
381 SKIN NECROSIS 1
382 SPEECH DISORDER 1
383 SPLENIC HAEMORRHAGE 1
384 SPLENIC INFARCTION 1
385 SPLENIC RUPTURE 1
386 STAPHYLOCOCCAL BACTERAEMIA 1
387 STAPHYLOCOCCAL SEPSIS 1
388 STAPHYLOCOCCUS TEST POSITIVE 1
389 STRESS 1
390 SUBCLAVIAN VEIN THROMBOSIS 1
391 SUBDURAL HAEMORRHAGE 1
392 SUDDEN DEATH 1
393 SYNCOPE 1
394 SYSTEMIC CANDIDA 1
395 TACHYCARDIA 1
396 TARDIVE DYSKINESIA 1
397 THERAPEUTIC PRODUCT EFFECT DELAYED 1
398 THERAPEUTIC RESPONSE UNEXPECTED 1
399 THROAT TIGHTNESS 1
400 THROMBOTIC STROKE 1
401 TRAUMATIC SHOCK 1
402 TREMOR 1
403 ULCER 1
404 URINARY INCONTINENCE 1
405 VASCULAR DEVICE INFECTION 1
406 VASCULAR OCCLUSION 1
407 VEIN COLLAPSE 1
408 VENA CAVA THROMBOSIS 1
409 VENOUS THROMBOSIS LIMB 1
410 VENTRICULAR ARRHYTHMIA 1
411 VENTRICULAR FIBRILLATION 1
412 VENTRICULAR TACHYCARDIA 1
413 VISUAL IMPAIRMENT 1
414 WRONG PATIENT RECEIVED PRODUCT 1
415 WRONG PRODUCT STORED 1
416 WRONG SCHEDULE 1
417 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1